// App-Quantinova.ai

e23014 : Glypican-5 to suppress NSCLC metastasis and EMT process by blocking Wnt/-catenin signaling pathway.

Researchers

Presenter

  • Mantang Qiu

Principal Investigators

  • Jie Wang

  • Wenjia Xia

  • Siwei Wang

  • Gaochao Dong

  • Rong Yin

  • Lin Xu

  • Youtao Xu

  • Xin Yang

Medical Centers

  • Nanjing Medical University, Nanjing, China

  • Cancer Institute of Jiangsu Province, Nanjing, China

  • The First People's Hospital of Changzhou, Changzhou, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

Biomarkers

  • Solute Carrier Family 22 Member 3

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved